This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Drug Discovery Technology Alert. Submental Contouring Injectable Drug Receives FDA Nod; Strategic Procedure to Prepare More Reliable Antibody Drug Conjugates; Treatment for Irritable Bowel Syndrome Gets Approval from FDA
Drug Discovery Technology Alert. Submental Contouring Injectable Drug Receives FDA Nod; Strategic Procedure to Prepare More Reliable Antibody Drug Conjugates; Treatment for Irritable Bowel Syndrome Gets Approval from FDA
RELEASE DATE
12-Jun-2015
12-Jun-2015
REGION
Global
Global
Deliverable Type
Technology Alert
Technology Alert
Research Code: D950-00-63-00-00
SKU: HC02725-GL-TA_19619
$950.00
In stock
SKU
HC02725-GL-TA_19619
Description
This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.
Table of Contents
In This Issue
- 1. SUBMENTAL CONTOURING INJECTABLE DRUG RECEIVES FDA NOD
- 2. TREATMENT FOR IRRITABLE BOWEL SYNDROME GETS APPROVAL FROM FDA
- 3. CHRONIC HEART FAILURE MEDICINE TO REDUCE HOSPITALIZATION RISK
- 4. ANTIBODY DRUG CONJUGATE PLATFORM TO TREAT CANCER
- 5. ADVANCES IN CANCER THERAPEUTICS THROUGH ANTIBODY-BASED TECHNOLOGY PLATFORM
- 6. STRATEGIC PROCEDURE TO PREPARE MORE RELIABLE ANTIBODY DRUG CONJUGATES
- 7. COMBINED ANTIBODY DRUG CONJUGATION THERAPY TO TREAT CANCER
- 8. GLOBAL PATENTS FOR THE TREATMENT OF GOUTY ARTHRITIS
- 9. TECHVISION 2015
Popular Topics
This issue profiles a submental contouring injectable drug that has been approved by FDFA, treatment for irritable bowel syndrome that has obtained FDA approval, and a strategic procedure to prepare more reliable antibody drug conjugates.
| Deliverable Types | Technology Alert |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | D950-00-63-00-00 |
| Is Prebook | No |
| Ti Codes | D951 |